ADAMTS1
Reactivité: Rat
WB, IHC, IF/ICC, IP
Hôte: Lapin
Polyclonal
unconjugated
Indications d'application
The stated application concentrations are suggested starting amounts. Titration of the ADAMTS1 antibody may be required due to differences in protocols and secondary/substrate sensitivity.\. Western blot: 0.5-1 μg/mL
Restrictions
For Research Use only
Buffer
0.5 mg/mL if reconstituted with 0.2 mL sterile DI water
Stock
-20 °C
Stockage commentaire
After reconstitution, the ADAMTS1 antibody can be stored for up to one month at 4°C. For long-term, aliquot and store at -20°C. Avoid repeated freezing and thawing.
Antigène
ADAMTS1
(ADAM Metallopeptidase with Thrombospondin Type 1 Motif, 1 (ADAMTS1))
anticorps c3-c5, anticorps meth1, anticorps xadamts1, anticorps C3-C5, anticorps METH1, anticorps ADAM-TS1, anticorps ADAMTS, anticorps ADAMTS-1, anticorps METH-1, anticorps adamts1, anticorps ADAM metallopeptidase with thrombospondin type 1 motif 1, anticorps ADAM metallopeptidase with thrombospondin type 1 motif, 1, anticorps a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 1, anticorps ADAM metallopeptidase with thrombospondin type 1 motif 1 L homeolog, anticorps ADAMTS1, anticorps adamts1, anticorps Adamts1, anticorps adamts1.L
Sujet
A Disintegrin-Like and Metalloproteinase with Thrombospondin Type 1 Motif, 1, also known as METH1, is an enzyme that in humans is encoded by the ADAMTS1 gene. ADAMTS is a family of proteins believed to be anchored to the extracellular matrix(ECM) through interactions with aggregan or other matrix components by one or more thrombospondin type 1 motifs. Scott(2000) mapped the gene to 21q21.2 based on sequence similarity between the ADAMTS1 sequence and a chromosome 21q21.2 clone. Kuno et al.(1997) found that mouse Adamts1 expression could be induced in vitro in colon adenocarcinoma cells by stimulation with the inflammatory cytokine interleukin 1-alpha, or in vivo in kidney and heart by intravenous administration of lipopolysaccharide. Vazquez et al.(1999) determined that ADAMTS1 disrupts angiogenesis in vivo and in vitro more efficiently than ADAMTS8, THBS1, or endostatin.